Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Triple negative breast cancer (BC) is an aggressive, poor-prognosis of breast cancer for which a clear clinical need exist...
Upcoming SlideShare
Loading in …5
×

Art Of Breast Cancer

723 views

Published on

ART3, frequently overexpressed in triple negative breast cancer, is a novel diagnostic marker candidate for aggressive, poor prognosis breast cancer

  • Be the first to comment

  • Be the first to like this

Art Of Breast Cancer

  1. 1. Triple negative breast cancer (BC) is an aggressive, poor-prognosis of breast cancer for which a clear clinical need exists because this sub-type of BC is refractory to hormone-therapy and herceptin.<br />Meta-analysis of 3 independent breast cancer data sets demonstrates that triple negative breast cancer, which does not express the traditional markers of BC including ESR, PGR, and Her2/Neu, contains significantly elevated levels of ART3 mRNA. Hence, ART3 is a novel candidate marker for triple negative BC.<br />No previously published data about ART3 in triple negative breast cancer exist. I carried out the current BC meta-analysis on data produced by unrelated whole-genome expression technologies. I did so in order to reduce the chance of technology-specific errors. Please use the GEO IDs in the above table to find the specific data sources at GEO website.<br />-MehisPold, M.D.<br />E-mail: mehisp@hotmail.com<br />Copyright © Eomix, Inc.<br />

×